BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12183610)

  • 1. Drug targeting. Breaking down barriers.
    Miller G
    Science; 2002 Aug; 297(5584):1116-8. PubMed ID: 12183610
    [No Abstract]   [Full Text] [Related]  

  • 2. Production and characterization of fusion proteins containing transferrin and nerve growth factor.
    Park E; Starzyk RM; McGrath JP; Lee T; George J; Schutz AJ; Lynch P; Putney SD
    J Drug Target; 1998; 6(1):53-64. PubMed ID: 9769021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Breaking down barriers--about the art of escorting drugs into the brain].
    Kahl U
    Lakartidningen; 2003 Jan; 100(3):136-7. PubMed ID: 12596480
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeted delivery across the blood-brain barrier.
    Gaillard PJ; Visser CC; de Boer AG
    Expert Opin Drug Deliv; 2005 Mar; 2(2):299-309. PubMed ID: 16296755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of blood-brain barrier permeability.
    Rapoport SI
    J Drug Target; 1996; 3(6):417-25. PubMed ID: 8863135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug delivery to the brain with nanoparticles].
    Aliautdin RN; Kreuter J; Kharkevich DA
    Eksp Klin Farmakol; 2003; 66(2):65-8. PubMed ID: 12962052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier.
    Silva GA
    Surg Neurol; 2007 Feb; 67(2):113-6. PubMed ID: 17254859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Pardridge WM
    Biotechnol Bioeng; 2007 Feb; 96(2):381-91. PubMed ID: 16937408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of hyperthermia on tight junctions between endothelial cells of the blood-brain barrier model in vitro].
    Chen YZ; Xu RX; Huang QJ; Xu ZJ; Jiang XD; Cai YQ
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan; 23(1):21-4. PubMed ID: 12527507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric nanoparticles for the drug delivery to the central nervous system.
    Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
    Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-brain barrier drug targeting: the future of brain drug development.
    Pardridge WM
    Mol Interv; 2003 Mar; 3(2):90-105, 51. PubMed ID: 14993430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of peptides in blood-brain barrier nanotechnology.
    Teixidó M; Giralt E
    J Pept Sci; 2008 Feb; 14(2):163-73. PubMed ID: 18085720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-mediated transport of therapeutics across the blood-brain barrier.
    Friden PM
    Neurosurgery; 1994 Aug; 35(2):294-8; discussion 298. PubMed ID: 7969837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New protein vectors for physiological transfer of therapeutic agents to the central nervous system].
    Gabathuler R
    Biol Aujourdhui; 2012; 206(3):191-203. PubMed ID: 23171842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug and gene targeting to the brain with molecular Trojan horses.
    Pardridge WM
    Nat Rev Drug Discov; 2002 Feb; 1(2):131-9. PubMed ID: 12120094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries.
    Hülsermann U; Hoffmann MM; Massing U; Fricker G
    J Drug Target; 2009 Sep; 17(8):610-8. PubMed ID: 19694613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice.
    Nico B; Frigeri A; Nicchia GP; Corsi P; Ribatti D; Quondamatteo F; Herken R; Girolamo F; Marzullo A; Svelto M; Roncali L
    Glia; 2003 May; 42(3):235-51. PubMed ID: 12673830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug delivery to the brain using an anti-transferrin receptor antibody.
    Friden PM; Walus L; Taylor M; Musso GF; Abelleira SA; Malfroy B; Tehrani F; Eckman JB; Morrow AR; Starzyk RM
    NIDA Res Monogr; 1992; 120():202-17. PubMed ID: 1501686
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation of the presence of blood-brain barrier tight junctions and expression of zonula occludens protein ZO-1 in vitro: a freeze-fracture and immunofluorescence study.
    Gao P; Shivers RR
    J Submicrosc Cytol Pathol; 2004 Jan; 36(1):7-15. PubMed ID: 15311669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Structural and cytochemical parameters of basement membranes in regions of blood brain barrier development during human prenatal ontogenesis].
    Korzhevskiĭ DE; Otellin VA
    Zh Evol Biokhim Fiziol; 2004; 40(4):365-9. PubMed ID: 15481377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.